Medical Health & Life Science Research News

Cancer immunotherapy market forecast to 2021 detailed in new research report

Cancer immunotherapy market forecast to 2021 detailed in new research report

Factors such as increasing incidence of cancer, rising healthcare expenditure, and increased access to medical insurance in developed countries are driving growth in the caner immunotherapy market.

- Agency -.

Inquire Before Buying @ goo.gl/SXVG7s

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. 

However, stringent regulatory policies and side-effects associated with cancer therapy are the major factors restraining the growth of this market.

The global cancer immunotherapy market has been segmented on the basis of type, application, enduser, and region.

- Agency -.

The monoclonal antibodies segment is expected to register the highest growth rate in the cancer immunotherapy market, by type, during the forecast period.

Factors such as high success rate and less recovery time are contributing to the high growth in this segment.

Access This Report @ goo.gl/oEEPc2

Based on application, the global cancer immunotherapy market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head & neck cancer, and others (renal cell carcinoma, cervical, gastric, and lymphoma). The lung cancer segment is expected to witness the highest CAGR from 2016 to 2021, primarily due to the rising prevalence of this type of cancer.

Based on endusers, the global cancer immunotherapy market is segmented into hospitals and clinics & others. The hospitals segment is expected to account for the largest share of the global cancer immunotherapy market in 2016.

The rise in healthcare spending has resulted in the increasing use of drugs in hospitals.

Key Points From Table Of Content:

5 Market Overview

5.1 Introduction
5.1.1 Drivers
5.1.1.1 Rise in Incidence Rate of Cancer Worldwide
5.1.1.2 Increase in Adoption of Immunotherapy Over Other Treatment Options
5.1.1.3 Development of Bioinformatics Tools are Enhancing Drug Development Process
5.1.2 Restraints
5.1.2.1 High Cost of Treatment
5.1.3 Opportunities
5.1.3.1 Increase in Clinical Trials Against Several Types of Cancers in Immunotherapy
5.1.3.2 High Growth Projections in the Developing Countries
5.1.4 Challenges
5.1.4.1 Availability of Limited Funds to Initiate Clinical Trials
5.1.4.2 Complexity of Cancer May Limit the Immune Response
5.2 Overview of Global Cancer Immunotherapy Funding

Download sample copy @ goo.gl/HsLP25

12 Company Profile

(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*

12.1 Amgen Inc.
12.2 Astrazeneca
12.3 Bayer AG
12.4 Bristol-Myers Squibb
12.5 Eli Lilly and Company
12.6 Janssen Global Services, LLC (Johnson and Johnson)
12.7 Merck
12.8 Novartis
12.9 Pfizer
12.10 F. Hoffmann-LA Roche Ltd.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.